61.23
前日終値:
$61.29
開ける:
$61.31
24時間の取引高:
2.15M
Relative Volume:
0.75
時価総額:
$11.59B
収益:
$2.83B
当期純損益:
$-1.02B
株価収益率:
-11.11
EPS:
-5.51
ネットキャッシュフロー:
$194.14M
1週間 パフォーマンス:
+4.95%
1か月 パフォーマンス:
+16.90%
6か月 パフォーマンス:
+47.26%
1年 パフォーマンス:
-11.56%
Exact Sciences Corp Stock (EXAS) Company Profile
EXAS を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
EXAS
Exact Sciences Corp
|
61.23 | 11.60B | 2.83B | -1.02B | 194.14M | -5.51 |
![]()
TMO
Thermo Fisher Scientific Inc
|
538.92 | 202.69B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
209.06 | 151.03B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
635.40 | 50.99B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
141.92 | 40.00B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
IQV
Iqvia Holdings Inc
|
204.55 | 34.98B | 15.70B | 1.24B | 2.01B | 6.9036 |
Exact Sciences Corp Stock (EXAS) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-04-10 | 開始されました | Mizuho | Outperform |
2025-03-13 | 開始されました | RBC Capital Mkts | Sector Perform |
2025-01-23 | 開始されました | Barclays | Overweight |
2024-08-28 | 開始されました | Wells Fargo | Overweight |
2024-06-27 | 開始されました | Scotiabank | Sector Outperform |
2024-06-03 | 再開されました | Jefferies | Buy |
2024-01-02 | アップグレード | The Benchmark Company | Hold → Buy |
2023-12-14 | 開始されました | Guggenheim | Buy |
2023-12-13 | 開始されました | Wolfe Research | Outperform |
2023-10-10 | アップグレード | Piper Sandler | Neutral → Overweight |
2023-09-28 | 開始されました | Bernstein | Outperform |
2023-08-02 | ダウングレード | The Benchmark Company | Buy → Hold |
2023-05-10 | アップグレード | Craig Hallum | Hold → Buy |
2023-05-05 | 開始されました | UBS | Neutral |
2023-03-09 | アップグレード | Citigroup | Neutral → Buy |
2023-02-10 | ダウングレード | Credit Suisse | Outperform → Neutral |
2023-01-18 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2022-10-19 | ダウングレード | Craig Hallum | Buy → Hold |
2022-08-25 | 開始されました | Credit Suisse | Outperform |
2022-06-03 | 開始されました | Piper Sandler | Neutral |
2021-11-03 | ダウングレード | Raymond James | Strong Buy → Outperform |
2021-07-29 | 繰り返されました | BTIG Research | Buy |
2021-07-29 | 繰り返されました | Canaccord Genuity | Buy |
2021-07-29 | 繰り返されました | Oppenheimer | Outperform |
2021-07-29 | 繰り返されました | Stifel | Buy |
2021-06-15 | 開始されました | Raymond James | Strong Buy |
2021-06-03 | 開始されました | Goldman | Buy |
2021-05-25 | 開始されました | Wells Fargo | Equal Weight |
2021-01-28 | 開始されました | Truist | Buy |
2020-10-29 | ダウングレード | UBS | Buy → Neutral |
2020-10-28 | ダウングレード | Citigroup | Buy → Neutral |
2020-10-08 | 再開されました | BTIG Research | Buy |
2020-04-02 | 開始されました | Evercore ISI | Outperform |
2020-01-10 | 再開されました | BTIG Research | Buy |
2020-01-07 | 開始されました | Citigroup | Buy |
2019-12-13 | 開始されました | Dougherty & Company | Buy |
2019-11-15 | 開始されました | Stifel | Buy |
2019-10-17 | 繰り返されました | BofA/Merrill | Buy |
2019-10-01 | 再開されました | Craig Hallum | Buy |
2019-09-26 | 開始されました | Oppenheimer | Outperform |
2019-02-26 | アップグレード | Goldman | Neutral → Buy |
2018-10-09 | 開始されました | UBS | Buy |
2018-09-05 | 再開されました | The Benchmark Company | Hold |
2018-08-13 | 繰り返されました | Canaccord Genuity | Buy |
2018-04-03 | アップグレード | BTIG Research | Neutral → Buy |
2018-01-29 | 開始されました | Goldman | Neutral |
2018-01-08 | 繰り返されました | The Benchmark Company | Buy |
2017-11-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2017-11-01 | ダウングレード | BTIG Research | Buy → Neutral |
すべてを表示
Exact Sciences Corp (EXAS) 最新ニュース
Backtesting results for Exact Sciences Corporation trading strategies - newser.com
Published on: 2025-10-15 10:07:11 - newser.com
Will Exact Sciences Corporation (EXK) stock announce special dividendPortfolio Performance Summary & AI Forecasted Entry/Exit Points - newser.com
Cancer screening innovation: The science behind multi-cancer early detection (MCED) tests - Modern Healthcare
Why Exact Sciences Corporation stock is in analyst buy zoneWeekly Volume Report & AI Driven Price Forecasts - newser.com
Is Exact Sciences Corporation stock a buy in volatile markets2025 Buyback Activity & Expert Approved Trade Ideas - newser.com
How high can Exact Sciences Corporation stock goRate Hike & High Yield Equity Trading Tips - newser.com
Published on: 2025-10-12 23:07:32 - newser.com
EXACT Sciences Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
What’s the recovery path for long term holders of Exact Sciences CorporationNew Guidance & Safe Entry Trade Reports - newser.com
Exact Sciences Corporation $EXAS Shares Sold by Blair William & Co. IL - MarketBeat
Doyle, Exact Sciences director, sells $120k in shares By Investing.com - Investing.com Australia
Herriott James, Exact Sciences SVP, sells $90k in EXAS stock - Investing.com Canada
Insider Sell: James Doyle Sells 2,000 Shares of Exact Sciences C - GuruFocus
Doyle, Exact Sciences director, sells $120k in shares - Investing.com India
Can Exact Sciences Corporation (EXK) stock sustain institutional flowsJuly 2025 Final Week & Daily Profit Focused Stock Screening - newser.com
Here's Why Exact Sciences (EXAS) is a Strong Momentum Stock - Yahoo Finance
What analysts say about Exact Sciences Corporation EXK stockFibonacci Extensions & Free Unmatched Market Gains - earlytimes.in
Exact Sciences (EXAS): Taking Stock of Valuation Following Recent Share Price Momentum - Yahoo Finance
Piper Sandler raises Exact Sciences stock price target to $70 on Cologuard growth - Investing.com India
EXAS: Piper Sandler Raises Price Target to $70, Maintains Overwe - GuruFocus
Piper Sandler raises Exact Sciences stock price target to $70 on Cologuard growth By Investing.com - Investing.com South Africa
Exact Sciences Corp.New Study in Journal of the National Cancer Institute Finds Cologuard Plus Provides the Most Life-Years Gained with the Fewest Colonoscopies - MarketScreener
Exact Sciences (NASDAQ:EXAS) Upgraded at Zacks Research - MarketBeat
Exact Sciences Corporation $EXAS Shares Bought by Gagnon Securities LLC - MarketBeat
Press Release: Exact Sciences Schedules Third Quarter 2025 Earnings Call - 富途牛牛
Exact Sciences Schedules Third Quarter 2025 Earnings Call - Business Wire
Exact Sciences Corporation $EXAS Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Evercore ISI Group Raises Price Target for EXAS to $68.00 | EXAS Stock News - GuruFocus
Are Medical Stocks Lagging Exact Sciences (EXAS) This Year? - Yahoo Finance
Here's How Much a $1000 Investment in Exact Sciences Made 10 Years Ago Would Be Worth Today - Yahoo Finance
Study finds Cologuard Plus efficient for colorectal cancer screening By Investing.com - Investing.com Nigeria
Study finds Cologuard Plus efficient for colorectal cancer screening - Investing.com
New Study in Journal of the National Cancer Institute Finds Cologuard Plus™ Provides the Most Life-Years Gained with the Fewest Colonoscopies - Yahoo Finance
Real time pattern detection on Exact Sciences Corporation stockWeekly Profit Analysis & Weekly High Momentum Picks - newser.com
Will Exact Sciences Corporation see short term momentumTrade Ideas & Fast Moving Market Watchlists - newser.com
How Recent Developments Are Reshaping the Story for Exact Sciences - Yahoo Finance
Will Analyst Upgrades and Earnings Revisions Shift Exact Sciences' (EXAS) Investment Narrative? - simplywall.st
Exact Sciences (EXAS): Evaluating Upside Potential as Analyst Optimism and New Catalysts Drive Attention - simplywall.st
Best data tools to analyze Exact Sciences Corporation stockTrade Risk Summary & Technical Pattern Based Signals - newser.com
How sentiment analysis helps forecast Exact Sciences Corporation2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com
Using economic indicators to assess Exact Sciences Corporation potentialTrade Risk Assessment & Precise Trade Entry Recommendations - newser.com
Will Exact Sciences Corporation stock deliver consistent dividendsWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Is Exact Sciences Corporation forming a reversal patternJuly 2025 Snapshot & Stock Portfolio Risk Control - newser.com
EXAS: Barclays Raises Price Target to $65.00 Amid Overweight Rat - GuruFocus
Here's Why Exact Sciences (EXAS) is a Strong Growth Stock - Yahoo Finance
Exact Sciences (EXAS) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance
Published on: 2025-10-01 06:45:18 - newser.com
Benchmark raises Exact Sciences stock price target to $60 on cancer test launch - Investing.com
Exact Sciences Corp (EXAS) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):